By Michelle Yang Researchers from Mie University in Japan used the gene editing tool CRISPR to remove the extra chromosome 21, the copy responsible for Down syndrome. Courtesy of digitale.de via ...
Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing ...
CRISPR Therapeutics AG is a long-term buy despite slow Casgevy uptake. Click for my updated look at CRSP earnings and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback